Characteristic | Colombia (N = 277) | Brazil (N = 130) | Mexico (N = 83) | Argentina (N = 56) | All Patients Latin America Subregion (N = 546) |
---|---|---|---|---|---|
Maternal history of osteoporosis or hip fracture, n (%) | 57 (23.4%) | 37 (40.2%) | 23 (39.7%) | 14 (30.4%) | 131 (29.8%) |
Sight problems, n (%) | 133 (50.6%) | 84 (68.9%) | 22 (26.5%) | 24 (42.9%) | 263 (50.2%) |
Patients experiencing falls in the past year, n (%) | 103 (38.6%) | 39 (31.5%) | 44 (62.9%) | 18 (34.0%) | 204 (39.7%) |
Number of falls in the past year, n (%) | |||||
No falls | 164 (61.4%) | 85 (68.5%) | 26 (37.1%) | 35 (66.0%) | 310 (60.3%) |
1 fall | 62 (23.2%) | 24 (19.4%) | 14 (20.0%) | 10 (18.9%) | 110 (21.4%) |
2 falls | 21 (7.9%) | 7 (5.6%) | 9 (12.9%) | 3 (5.7%) | 40 (7.8%) |
3 or more falls | 20 (7.5%) | 8 (6.5%) | 21 (30.0%) | 5 (9.4%) | 54 (10.5%) |
Hours of exercise per week, mean (SD) | 2.6 (8.3) | 1.2 (1.8) | 2.1 (2.6) | 2.0 (2.4) | 2.1 (6.2) |
Use of arms when standing up from a chair, n (%) | 159 (58.2%) | 74 (59.2%) | 57 (68.7%) | 17 (30.4%) | 307 (57.2%) |
Immobilized for > 12 months, n (%) | 3 (1.1%) | 6 (4.8%) | 1 (1.2%) | 1 (1.8%) | 11 (2.1%) |
Currently smoking, n (%) | 16 (5.9%) | 9 (7.0%) | 10 (12.0%) | 4 (7.1%) | 39 (7.2%) |
Alcoholic drinks per week, mean (SD) | 0.2 (1.2) | 0.3 (1.1) | 0.2 (0.8) | 0.4 (1.9) | 0.2 (1.2) |
Caffeinated drinks per week, mean (SD) | 8.1 (9.6) | 11.0 (13.6) | 7.2 (6.0) | 3.4 (5.0) | 8.2 (10.2) |
Patients with current comorbidities a, n (%) | |||||
Hypertension | 124 (44.8%) | 66 (51.2%) | 37 (44.6%) | 25 (44.6%) | 252 (46.2%) |
Rheumatoid arthritis or other rheumatologic conditions | 81 (29.5%) | 17 (13.4%) | 19 (22.9%) | 6 (10.9%) | 123 (22.8%) |
Type 2 diabetes mellitus | 18 (6.5%) | 18 (14.3%) | 8 (9.6%) | 1 (1.8%) | 45 (8.3%) |
Concomitant medicationsb, n (%) | |||||
Antihypertensives | 83 (30.0%) | 61 (46.9%) | 30 (36.1%) | 17 (30.4%) | 191 (35.0%) |
Thyroid hormones | 63 (22.7%) | 18 (13.8%) | 18 (21.7%) | 17 (30.4%) | 116 (21.2%) |
Antidepressants | 15 (5.4%) | 24 (18.5%) | 1 (1.2%) | 3 (5.4%) | 43 (7.9%) |
Insulins/oral hypoglycemics | 20 (7.2%) | 14 (10.8%) | 5 (6.0%) | 1 (1.8%) | 40 (7.3%) |
Glucocorticoidsc | 12 (7.5%) | 7 (8.0%) | 0 (0.0%) | 1 (2.9%) | 20 (6.2%) |